What psychostimulant dose is ‘just right’ for people with ADHD? This blog explores the first dose-effect network meta-analysis across age groups, unpacking what it means for clinicians navigating the fine line between therapeutic inertia and unnecessary dose escalation.
[read the full story...]
Clozapine is the gold standard for treatment-resistant schizophrenia, but could it help beyond that? A huge Nordic registry study of over 500,000 people asks whether its benefits stretch across other psychiatric disorders.
[read the full story...]
Around 30% of people with anorexia may screen positive for autism, yet treatment models rarely reflect this. A new qualitative review asks what autistic people actually need from eating disorder services.
[read the full story...]
People with schizophrenia die years earlier than the general population, often from heart disease. A new cardiovascular risk model adds psychiatric and social factors, and asks whether machine learning really improves prediction.
[read the full story...]
Irregular sleep and a weaker day-night activity contrast may flag depression relapse weeks before it happens. Could wrist-worn devices become part of relapse prevention?
[read the full story...]
Adolescents with mental health conditions spend more time on social media and engage with it differently, especially those with internalising conditions like anxiety or eating disorders. Let’s avoid thinking of ‘mental health’ as one category when it comes to young people’s lives on social media.
[read the full story...]
Many young people are clearly struggling but don’t fit any diagnosis. A new meta-analysis asks whether transdiagnostic support can help them before a label arrives.
Transdiagnostic interventions show small but consistent gains.
A systematic review of 22 million people finds several mental health conditions, including PTSD, depression and anxiety, are linked to higher acute coronary syndrome risk.
[read the full story...]
Fifty years after Jerome Motto’s caring letters, this meta-analysis suggests brief interventions can help people through the high-risk period after a suicide attempt. However, we still don’t know how they work.
[read the full story...]
Approach Bias Modification didn’t significantly beat standard smoking cessation care, but this may say more about the trial’s power than the intervention itself.
[read the full story...]
